360 related articles for article (PubMed ID: 10888242)
1. Induction of cardiac fibrosis by aldosterone.
Lijnen P; Petrov V
J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
[TBL] [Abstract][Full Text] [Related]
2. Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling.
Lijnen PJ; Petrov VV
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):541-64. PubMed ID: 14571285
[TBL] [Abstract][Full Text] [Related]
3. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
5. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
Brilla CG; Zhou G; Matsubara L; Weber KT
J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
[TBL] [Abstract][Full Text] [Related]
6. [Profibrotic effects of aldosterone].
Van Den Meiracker AH; Huizenga AT; Boomsma F
Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1532-6. PubMed ID: 15366722
[TBL] [Abstract][Full Text] [Related]
7. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological modulation of cardiac fibroblast function.
Brilla CG; Maisch B; Rupp H; Funck R; Zhou G; Weber KT
Herz; 1995 Apr; 20(2):127-34. PubMed ID: 7774864
[TBL] [Abstract][Full Text] [Related]
9. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
Ramires FJ; Sun Y; Weber KT
J Mol Cell Cardiol; 1998 Mar; 30(3):475-83. PubMed ID: 9515025
[TBL] [Abstract][Full Text] [Related]
10. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
Bauersachs J; Fraccarollo D
Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of the renin-angiotensin-aldosterone system and collagen metabolism in cardiac fibroblasts.
Lijnen P; Petrov V
Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):215-27. PubMed ID: 10389125
[TBL] [Abstract][Full Text] [Related]
13. [The significance of aldosterone in chronic heart failure: the RALES study].
Simko F; Bada V; Simková M; Simko J; Kovács L; Hulín I
Vnitr Lek; 2002 Aug; 48(8):767-72. PubMed ID: 12425209
[TBL] [Abstract][Full Text] [Related]
14. Interactions of high salt intake and the response of the cardiovascular system to aldosterone.
Conlin PR
Cardiol Rev; 2005; 13(3):118-24. PubMed ID: 15831143
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies.
Pasquale PD; Stefano GD; Paterna S
Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838
[TBL] [Abstract][Full Text] [Related]
17. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
Erne P
Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration.
Sun Y; Weber KT
J Lab Clin Med; 1993 Oct; 122(4):404-11. PubMed ID: 8228554
[TBL] [Abstract][Full Text] [Related]
20. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.
Weber KT; Sun Y; Tyagi SC; Cleutjens JP
J Mol Cell Cardiol; 1994 Mar; 26(3):279-92. PubMed ID: 8028011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
